Methylprednisolone Alternatives Compared
Methylprednisolone | Rinvoq | Triamcinolone topical |
|
---|
Methylprednisolone | Rinvoq (upadacitinib) | Triamcinolone topical |
|
|||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Methylprednisolone effectively controls inflammation and an overactive immune system but may not be suitable for everybody. Long-term use is limited by potentially severe side effects such as... View more |
Prescription only
Prescribed for Crohn's Disease, Ankylosing Spondylitis, Atopic Dermatitis, Non-Radiographic Axial Spondyloarthritis, Polyarticular Juvenile Idiopathic Arthritis, Psoriatic Arthritis, Rheumatoid... View more |
Prescription only
Prescribed for Atopic Dermatitis, Dermatitis, Aphthous Ulcer, Allergies, Eczema, Lichen Planus, Psoriasis, Stomatitis. triamcinolone topical may also be used for purposes not listed in this medication guide. View more |
Related suggestions Atopic Dermatitis
|
|||||||||||||||||||||||
More about Methylprednisolone | More about Rinvoq (upadacitinib) | More about Triamcinolone topical | ||||||||||||||||||||||||
Ratings & Reviews | ||||||||||||||||||||||||||
Methylprednisolone has an average rating of 7.1 out of 10 from a total of 467 ratings on Drugs.com. 64% of reviewers reported a positive effect, while 25% reported a negative effect. |
Rinvoq has an average rating of 6.8 out of 10 from a total of 172 ratings on Drugs.com. 54% of reviewers reported a positive effect, while 23% reported a negative effect. |
Triamcinolone topical has an average rating of 7.6 out of 10 from a total of 104 ratings on Drugs.com. 69% of reviewers reported a positive effect, while 20% reported a negative effect. |
||||||||||||||||||||||||
Drug Class | ||||||||||||||||||||||||||
Side Effects | ||||||||||||||||||||||||||
See also: methylprednisolone side effects in more detail. |
See also: Rinvoq side effects in more detail. |
See also: triamcinolone topical side effects in more detail. |
||||||||||||||||||||||||
Generic Availability | ||||||||||||||||||||||||||
Lower cost generic |
Lower cost generic |
|||||||||||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all methylprednisolone prices |
View all Rinvoq prices |
View all triamcinolone topical prices |
||||||||||||||||||||||||
Dosage Form(s) Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Brand Names | ||||||||||||||||||||||||||
Depo-Medrol, Medrol, Medrol Dosepak, MethylPREDNISolone Dose Pack, Solu-Medrol | Other upadacitinib brands include: Rinvoq LQ | Aricin, Aristocort A, Aristocort R, Cinalog, Cinolar, Delta-Tritex, DermacinRx Silazone, DermacinRx Trizapak, Dermasorb TA, Juulissa Pharmapak, Kenalog, Kourzeq, Oralone, SilaLite Pak, Treziopak, Trianex, Triasil, Triderm, Tritocin View more | ||||||||||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
3.5 hours |
14 hours |
N/A |
||||||||||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
Pregnancy Category | ||||||||||||||||||||||||||
Category C
Risk cannot be ruled out
Excluding First Trimester
Category D
Positive evidence of risk
First Trimester See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||||||||||
Drug Interactions | ||||||||||||||||||||||||||
A total of 588 drugs are known to interact with methylprednisolone:
|
A total of 550 drugs are known to interact with Rinvoq:
|
A total of 48 drugs are known to interact with triamcinolone topical:
|
||||||||||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
Disease Interactions | ||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
First Approval Date | ||||||||||||||||||||||||||
October 24, 1957 |
August 16, 2019 |
October 23, 1958 |
||||||||||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
N/A |
||||||||||||||||||||||||||
More Information | ||||||||||||||||||||||||||
Patient resources | ||||||||||||||||||||||||||
Professional Resources | ||||||||||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||||||||||
|
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.